Work

Abstract PS4-07-17: Results of the Dose-Expansion Cohort of a Phase 1 Trial of Intratumoral HER2- and HER3-Primed Dendritic Cells Injections for the Treatment of Early-Stage TNBC and HR Low Positive Breast Cancer.DecipHER trial

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-07-17

Authors: R. Costa, A. Soyano, A. Armaghani, N. Abdo, S. Wallace-Morrison, M. Al-Jumayli, L. Loftus, E. Abraham, J. Whiting, Q. Mo, Z. Jameel, T. O'Connor, K. Dvir, S. Hoover, J. Kiluk, M. Lee, C. Laronga, N. Khakpour, H. Han, H. Soliman, B. Czerniecki

Institution: Moffitt Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129603118

Cites:

Cited by:

Related to: